Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Cash from Investing (Quarterly): 22.70M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.70M |
| September 30, 2023 | 42.63M |
| June 30, 2023 | -10.88M |
| March 31, 2023 | 55.42M |
| December 31, 2022 | 17.57M |
| September 30, 2022 | 16.96M |
| June 30, 2022 | 23.28M |
| March 31, 2022 | -64.63M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.338M |
| September 30, 2021 | 18.76M |
| June 30, 2021 | -32.04M |
| March 31, 2021 | -169.63M |
| December 31, 2020 | -31.35M |
| September 30, 2020 | -0.226M |
| June 30, 2020 | -0.104M |
| March 31, 2020 | -0.029M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-169.63M
Minimum
Mar 2021
55.42M
Maximum
Mar 2023
-6.828M
Average
1.154M
Median
Cash from Investing (Quarterly) Benchmarks
| XOMA Corp | 5.511M |
| Societal CDMO Inc (DELISTED) | -0.734M |
| NGM Biopharmaceuticals Inc (DELISTED) | 27.19M |
| Avrobio Inc | 0.15M |
| Landos Biopharma Inc | 0.063M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.36M |
| Free Cash Flow | -100.04M |
| Free Cash Flow Per Share (Quarterly) | -0.3685 |
| Free Cash Flow Yield | -81.06% |